Opinion|Videos|June 28, 2024
CLL Treatment Landscape: Overview of BTK Inhibitors
A panel of experts provide an overview of BTK inhibitors for the treatment of patients with chronic lymphocytic leukemia.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- Provide an overview of the current landscape of treatment-naïve CLL treatment options. Where do the BTK inhibitors fit into this landscape?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
3
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
4
COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says
5